Skip to main content
Fig. 6 | CABI Agriculture and Bioscience

Fig. 6

From: Technical considerations towards commercialization of porcine respiratory and reproductive syndrome (PRRS) virus resistant pigs

Fig. 6

Scaled breeding steps for 1st, 2nd and 3rd generation of pigs to generate gene edited nucleus herd. A Advancing PRRSV resistance allele. Mosaic E0 pigs screened and identified to contain the desired CD163 allele are bred to wild-type gilts or boars to produce heterozygous CD163 (CD163m/WT) pigs. All E1 pigs are screened by Illumina and a subset then sequenced by hybridization capture to advance CD163m/WT pigs that do not contain detected off-target INDELs for breeding. E1 CD163m/WT pigs are then crossbred to fix the modified CD163 in a homozygous state (CD163m/m). These E2 CD163m/m pigs are then used for virus resistance testing, commercial performance equivalency, regulatory data submission and advanced for nucleus multiplication. CD163m/m pigs across four lines enter production pyramid upon approval. B Nucleus and conventional breeding. Approximately 10–20 high genetic merit CD163m/m boars across 2 maternal and 2 paternal lines are used to maintain a small nucleus population for multiplication and genetic improvement. Upon approval, these founders would be multiplied and distributed to producers for commercial production and sale using conventional breeding practices

Back to article page